Incyte Corporation (BIT:1INCY)
73.26
+7.16 (10.83%)
At close: Aug 14, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
JAKAFI | 2.79B | Log In | Log In | Log In | Log In | Upgrade |
JAKAFI Growth | 14.50% | Log In | Log In | Log In | Log In | Upgrade |
JAKAVI Product Royalty | 418.84M | Log In | Log In | Log In | Log In | Upgrade |
JAKAVI Product Royalty Growth | 10.90% | Log In | Log In | Log In | Log In | Upgrade |
Milestone and Contract | 43.00M | Log In | Log In | Log In | Log In | Upgrade |
Milestone and Contract Growth | - | Log In | Log In | Log In | Log In | Upgrade |
ICLUSIG | 114.32M | Log In | Log In | Log In | Log In | Upgrade |
ICLUSIG Growth | 6.54% | Log In | Log In | Log In | Log In | Upgrade |
OLUMIANT Product Royalty | 135.57M | Log In | Log In | Log In | Log In | Upgrade |
OLUMIANT Product Royalty Growth | 4.01% | Log In | Log In | Log In | Log In | Upgrade |
PEMAZYRE | 81.75M | Log In | Log In | Log In | Log In | Upgrade |
PEMAZYRE Growth | 8.89% | Log In | Log In | Log In | Log In | Upgrade |
TABRECTA Product Royalty | 22.75M | Log In | Log In | Log In | Log In | Upgrade |
TABRECTA Product Royalty Growth | 30.54% | Log In | Log In | Log In | Log In | Upgrade |
OPZELURA | 508.29M | Log In | Log In | Log In | Log In | Upgrade |
OPZELURA Growth | 42.98% | Log In | Log In | Log In | Log In | Upgrade |
MINJUVI | 119.24M | Log In | Log In | Log In | Log In | Upgrade |
MINJUVI Growth | 72.71% | Log In | Log In | Log In | Log In | Upgrade |
Other Product Royalty | 2.17M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Royalty Growth | 25.48% | Log In | Log In | Log In | Log In | Upgrade |
ZYNYZ | 3.19M | Log In | Log In | Log In | Log In | Upgrade |
ZYNYZ Growth | 678.48% | Log In | Log In | Log In | Log In | Upgrade |